Iodide

Iodide

SCHEMBL3734832

Cc1cc[n+](C)c(NC(=O)C(Cc2ccccc2)n2cc(-c3ccc(S(N)(=O)=O)cc3)nn2)c1.[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.56
CA9 Q16790 6/20 0.56
CA1 P00915 6/20 0.56
CA5A P35218 6/20 0.56
CA5B Q9Y2D0 6/20 0.56
CA12 O43570 5/20 0.56
CA3 P07451 3/20 0.56
CA4 P22748 3/20 0.56
CA6 P23280 3/20 0.56
CA7 P43166 3/20 0.56
CA13 Q8N1Q1 3/20 0.56
CA14 Q9ULX7 3/20 0.56
PTGS2 P35354 6/20 0.40
MMP2 P08253 2/20 0.39
MMP9 P14780 2/20 0.39
MMP3 P08254 1/20 0.39
MMP10 P09238 1/20 0.39
MMP12 P39900 1/20 0.39
MMP14 P50281 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL3734831 1.00 CA2 (0.56) CA2CA9CA1CA5ACA5B
SCHEMBL13012707 0.99 CA2 (0.57) CA2CA9CA1CA5ACA5B
SCHEMBL13062324 0.88 CA12 (0.43) CA2CA9CA1CA5ACA5B
SCHEMBL3736021 0.85 CA2 (0.58) CA2CA9CA1CA5ACA5B
SCHEMBL3736023 0.85 CA2 (0.58) CA2CA9CA1CA5ACA5B
SCHEMBL3732390 0.80 CA2 (0.65) CA2CA9CA1CA5ACA5B
SCHEMBL3732387 0.80 CA2 (0.65) CA2CA9CA1CA5ACA5B
SCHEMBL3735515 0.79 CA2 (0.64) CA2CA9CA1CA5ACA5B
SCHEMBL3735518 0.79 CA2 (0.64) CA2CA9CA1CA5ACA5B
SCHEMBL3730647 0.78 CA2 (0.65) CA2CA9CA1CA5ACA5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354092-B2 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-01-15 US disclosed
EP-2468734-A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry Siemens Medical Solutions USA, Inc. (US) 2012-06-27 EP disclosed
US-20100317842-A1 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-12-16 US disclosed
US-7829063-B2 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-11-09 US disclosed
US-20090123372-A1 DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY SIEMENS MEDICAL SOLUTIONS USA, INC. 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317842-A1 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry CA9, CA4, CA13 CA2 9/4885CA9 1/4885CA1 5/4885
US-20090123372-A1 DEVELOPMENT OF MOLECULAR IMAGING PROBES FOR CARBONIC ANHYDRASE-IX USING CLICK CHEMISTRY CA9, CA4, CA13 CA2 9/4885CA9 1/4885CA1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.